Detalhe da pesquisa
1.
Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer.
Cancer
; 120(1): 77-85, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24108668
2.
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.
Clin Cancer Res
; 14(15): 4836-42, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18676756
3.
Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma.
Clin Cancer Res
; 25(7): 2080-2087, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635337
4.
Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancer.
Clin Cancer Res
; 8(10): 3100-4, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12374677
5.
Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy.
Cancer Chemother Pharmacol
; 52(3): 217-22, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12811513
6.
A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine.
Cancer Chemother Pharmacol
; 53(5): 404-8, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15129676
7.
Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.
Autophagy
; 10(8): 1391-402, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24991838
8.
Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study.
Cancer Chemother Pharmacol
; 68(5): 1111-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21350850
9.
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 65(1): 97-105, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19415281
10.
Phase II trial of sorafenib in advanced thyroid cancer.
J Clin Oncol
; 26(29): 4714-9, 2008 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18541894